Literature DB >> 18591227

Phenotypic switching in Cryptococcus neoformans contributes to virulence by changing the immunological host response.

Abraham Guerrero1, Bettina C Fries.   

Abstract

Cryptococcus neoformans is an encapsulated opportunistic organism that can undergo phenotypic switching. In this process, the parent smooth colony (SM) switches to a more virulent mucoid colony (MC) variant. The host responses mounted against the SM and MC variants differ, and lower tissue interleukin 10 (IL-10) levels are consistently observed in lungs of MC-infected C57BL/6 and BALB/c mice. This suggested different roles of this cytokine in SM and MC infections. The objective of this study was to compare survival rates and characterize the host responses of SM- and MC-infected IL-10-depleted (IL-10(-/-)) mice, which exhibit a Th1-polarized immune response and are considered resistant hosts. As expected, SM-infected IL-10(-/-) mice survived longer than wild-type mice, whereas MC-infected IL-10(-/-) mice did not exhibit a survival benefit. Consistent with this observation, we demonstrated marked differences in the inflammatory responses of SM- and MC-infected IL-10(-/-) and wild-type mice. This included a more Th1-polarized inflammatory response with enhanced recruitment of macrophages and natural killer and CD8 cells in MC- than in SM-infected IL-10(-/-) and wild-type mice. In contrast, both SM-infected IL-10(-/-) and wild-type mice exhibited higher recruitment of CD4 cells, consistent with enhanced survival and differences in recruitment and Th1/Th2 polarization. Lung tissue levels of IL-21, IL-6, IL-4, transforming growth factor beta, IL-12, and gamma interferon were higher in MC-infected IL-10(-/-) and wild-type mice than in SM-infected mice, whereas tumor necrosis factor alpha levels were higher in SM-infected IL-10(-/-) mice. In conclusion, the MC variant elicits an excessive inflammatory response in a Th1-polarized host environment, and therefore, the outcome is negatively affected by the absence of IL-10.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18591227      PMCID: PMC2519423          DOI: 10.1128/IAI.00529-08

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  64 in total

Review 1.  Host-pathogen interactions: the attributes of virulence.

Authors:  A Casadevall; L Pirofski
Journal:  J Infect Dis       Date:  2001-06-27       Impact factor: 5.226

2.  CCR2 expression determines T1 versus T2 polarization during pulmonary Cryptococcus neoformans infection.

Authors:  T R Traynor; W A Kuziel; G B Toews; G B Huffnagle
Journal:  J Immunol       Date:  2000-02-15       Impact factor: 5.422

3.  Both Th1 and Th2 cytokines affect the ability of monoclonal antibodies to protect mice against Cryptococcus neoformans.

Authors:  D O Beenhouwer; S Shapiro; M Feldmesser; A Casadevall; M D Scharff
Journal:  Infect Immun       Date:  2001-10       Impact factor: 3.441

4.  Effect of interleukin (IL)-15 priming on IL-12 and interferon-gamma production by pathogen-stimulated peripheral blood mononuclear cells from human immunodeficiency virus-seropositive and -seronegative donors.

Authors:  K E Parayath; T S Harrison; S M Levitz
Journal:  J Infect Dis       Date:  2000-02       Impact factor: 5.226

5.  HIV type 1 envelope glycoprotein gp120 induces development of a T helper type 2 response to Cryptococcus neoformans.

Authors:  D Pietrella; C Monari; C Retini; B Palazzetti; T R Kozel; A Vecchiarelli
Journal:  AIDS       Date:  1999-11-12       Impact factor: 4.177

6.  Cryptococcus neoformans is a facultative intracellular pathogen in murine pulmonary infection.

Authors:  M Feldmesser; Y Kress; P Novikoff; A Casadevall
Journal:  Infect Immun       Date:  2000-07       Impact factor: 3.441

7.  Interleukin-12 counterbalances the deleterious effect of human immunodeficiency virus type 1 envelope glycoprotein gp120 on the immune response to Cryptococcus neoformans.

Authors:  D Pietrella; T R Kozel; C Monari; F Bistoni; A Vecchiarelli
Journal:  J Infect Dis       Date:  2000-11-21       Impact factor: 5.226

8.  The role of macrophage inflammatory protein-1 alpha/CCL3 in regulation of T cell-mediated immunity to Cryptococcus neoformans infection.

Authors:  M A Olszewski; G B Huffnagle; R A McDonald; D M Lindell; B B Moore; D N Cook; G B Toews
Journal:  J Immunol       Date:  2000-12-01       Impact factor: 5.422

9.  Phagocytosis and protein processing are required for presentation of Cryptococcus neoformans mitogen to T lymphocytes.

Authors:  R M Syme; J C Spurrell; L L Ma; F H Green; C H Mody
Journal:  Infect Immun       Date:  2000-11       Impact factor: 3.441

10.  Variation in the structure of glucuronoxylomannan in isolates from patients with recurrent cryptococcal meningitis.

Authors:  R Cherniak; L C Morris; T Belay; E D Spitzer; A Casadevall
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

View more
  12 in total

1.  Cryptococcus neoformans variants generated by phenotypic switching differ in virulence through effects on macrophage activation.

Authors:  A Guerrero; N Jain; X Wang; B C Fries
Journal:  Infect Immun       Date:  2010-01-04       Impact factor: 3.441

2.  Role of dendritic cells and alveolar macrophages in regulating early host defense against pulmonary infection with Cryptococcus neoformans.

Authors:  John J Osterholzer; Jami E Milam; Gwo-Hsiao Chen; Galen B Toews; Gary B Huffnagle; Michal A Olszewski
Journal:  Infect Immun       Date:  2009-06-29       Impact factor: 3.441

Review 3.  Variability of phenotypic traits in Cryptococcus varieties and species and the resulting implications for pathogenesis.

Authors:  Gunjan Gupta; Bettina C Fries
Journal:  Future Microbiol       Date:  2010-05       Impact factor: 3.165

4.  Aging: an emergent phenotypic trait that contributes to the virulence of Cryptococcus neoformans.

Authors:  Tejas Bouklas; Bettina C Fries
Journal:  Future Microbiol       Date:  2015       Impact factor: 3.165

5.  Improved survival of mice deficient in secretory immunoglobulin M following systemic infection with Cryptococcus neoformans.

Authors:  Krishanthi S Subramaniam; Kausik Datta; Matthew S Marks; Liise-Anne Pirofski
Journal:  Infect Immun       Date:  2009-11-09       Impact factor: 3.441

6.  Virulence factors identified by Cryptococcus neoformans mutant screen differentially modulate lung immune responses and brain dissemination.

Authors:  Xiumiao He; Daniel M Lyons; Dena L Toffaletti; Fuyuan Wang; Yafeng Qiu; Michael J Davis; Daniel L Meister; Jeremy K Dayrit; Anthony Lee; John J Osterholzer; John R Perfect; Michal A Olszewski
Journal:  Am J Pathol       Date:  2012-07-28       Impact factor: 4.307

7.  Cryptococcal urease promotes the accumulation of immature dendritic cells and a non-protective T2 immune response within the lung.

Authors:  John J Osterholzer; Rishi Surana; Jami E Milam; Gerald T Montano; Gwo-Hsiao Chen; Joanne Sonstein; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews; Michal A Olszewski
Journal:  Am J Pathol       Date:  2009-02-13       Impact factor: 4.307

8.  Accumulation of CD11b+ lung dendritic cells in response to fungal infection results from the CCR2-mediated recruitment and differentiation of Ly-6Chigh monocytes.

Authors:  John J Osterholzer; Gwo-Hsiao Chen; Michal A Olszewski; Jeffrey L Curtis; Gary B Huffnagle; Galen B Toews
Journal:  J Immunol       Date:  2009-12-15       Impact factor: 5.422

Review 9.  Cryptococcosis: epidemiology, fungal resistance, and new alternatives for treatment.

Authors:  F P Gullo; S A Rossi; J de C O Sardi; V L I Teodoro; M J S Mendes-Giannini; A M Fusco-Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-07-04       Impact factor: 3.267

10.  Allergen1 regulates polysaccharide structure in Cryptococcus neoformans.

Authors:  Neena Jain; Radames J B Cordero; Arturo Casadevall; Bettina C Fries
Journal:  Mol Microbiol       Date:  2013-04-09       Impact factor: 3.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.